HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sinthia Bosnic-Anticevich Selected Research

Chronic Obstructive Pulmonary Disease (COPD)

12/2023Does mixing inhaler devices lead to unchecked inhaler technique errors in patients with COPD? Findings from the cross-sectional observational MISMATCH study.
8/2023Identifying critical inhalation technique errors in Dry Powder Inhaler use in patients with COPD based on the association with health status and exacerbations: findings from the multi-country cross-sectional observational PIFotal study.
1/2023Advancing Digital Solutions to Overcome Longstanding Barriers in Asthma and COPD Management.
1/2023Recognizing and Tackling Inhaler Technique Decay in Asthma and Chronic Obstructive Pulmonary Disesase (COPD) Clinical Practice.
12/2022Clinical recommendations for dry powder inhaler use in the management of COPD in primary care.
10/2022Real-World Impact of Nonclinical Inhaler Regimen Switches on Asthma or COPD: A Systematic Review.
1/2022Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers.
12/2021Impact of PIF, Inhalation Technique and Medication Adherence on Health Status and Exacerbations in COPD: Protocol of a Real-World Observational Study (PIFotal COPD Study).
1/2017The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes.
11/2016Incidence of oral thrush in patients with COPD prescribed inhaled corticosteroids: Effect of drug, dose, and device.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sinthia Bosnic-Anticevich Research Topics

Disease

39Asthma (Bronchial Asthma)
02/2024 - 08/2011
12Chronic Obstructive Pulmonary Disease (COPD)
12/2023 - 01/2016
9Rhinitis
07/2023 - 01/2018
9Allergic Rhinitis
01/2023 - 01/2016
6Hypersensitivity (Allergy)
01/2023 - 12/2018
2Respiratory Tract Diseases (Respiratory Tract Disease)
01/2023 - 12/2021
1Gastroesophageal Reflux (GERD)
07/2023
1Osteoporosis
01/2022
1Anaphylaxis (Anaphylactic Shock)
10/2021
1Chronic Disease (Chronic Diseases)
12/2020
1COVID-19
10/2020
1Oral Candidiasis (Thrush)
11/2016
1Obesity
01/2016
1Intellectual Disability (Idiocy)
01/2016

Drug/Important Bio-Agent (IBA)

17Adrenal Cortex Hormones (Corticosteroids)IBA
10/2022 - 11/2016
63- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA
02/2024 - 01/2019
3Formoterol Fumarate (Oxis)FDA Link
01/2022 - 06/2018
3AllergensIBA
12/2020 - 11/2019
2Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2019
2Bronchodilator Agents (Bronchodilators)IBA
01/2021 - 11/2016
1Fluticasone (Cutivate)FDA LinkGeneric
10/2022
1azelastine (Optivar)FDA LinkGeneric
10/2022
1SteroidsIBA
01/2022
1Prednisolone (Predate)FDA LinkGeneric
12/2021
1COVID-19 VaccinesIBA
10/2021
1AntibodiesIBA
12/2020
1Immunoglobulin E (IgE)IBA
12/2020
1Histamine Antagonists (Antihistamines)IBA
01/2020
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2019
1TitaniumIBA
12/2018
1TabletsIBA
12/2018
1Budesonide (Pulmicort)FDA LinkGeneric
06/2018
1ElementsIBA
04/2017

Therapy/Procedure

28Nebulizers and Vaporizers (Inhaler)
02/2024 - 08/2011
19Therapeutics
02/2024 - 08/2011
9Dry Powder Inhalers
12/2023 - 08/2011
5Drug Therapy (Chemotherapy)
11/2022 - 01/2016
4Metered Dose Inhalers (Metered Dose Inhaler)
12/2023 - 08/2011
2Self Medication
01/2019 - 07/2018
1Immunotherapy
11/2022
1Activities of Daily Living (ADL)
01/2022
1Injections
10/2021